The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(6-chloro-5-(2-chloro-5-(4-(methylamino)pyrimidin-2-ylamino)benzo[b]thiophen-3-yl)pyridin-3-yl)-3,6-dimethylpyrimidin-4(3H)-one ID: ALA4534250
PubChem CID: 155546745
Max Phase: Preclinical
Molecular Formula: C24H19Cl2N7OS
Molecular Weight: 524.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNc1ccnc(Nc2ccc3sc(Cl)c(-c4cc(-c5c(C)ncn(C)c5=O)cnc4Cl)c3c2)n1
Standard InChI: InChI=1S/C24H19Cl2N7OS/c1-12-19(23(34)33(3)11-30-12)13-8-16(21(25)29-10-13)20-15-9-14(4-5-17(15)35-22(20)26)31-24-28-7-6-18(27-2)32-24/h4-11H,1-3H3,(H2,27,28,31,32)
Standard InChI Key: ZYIUYTWUXIBOEY-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
15.0121 -25.9488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7278 -25.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7250 -24.7063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0104 -24.2977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4422 -25.9469 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1552 -25.5337 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8661 -25.9451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5787 -25.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5779 -24.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8586 -24.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1489 -24.7117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8543 -23.4728 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5659 -23.0571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2957 -25.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2994 -24.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5157 -24.4544 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.0277 -25.1198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5097 -25.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2036 -25.1160 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.2529 -26.5708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4448 -26.7374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1864 -27.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7353 -28.1350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5458 -27.9639 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.8003 -27.1823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6068 -27.0124 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.3786 -27.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8297 -27.0707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0218 -27.2382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7629 -28.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3118 -28.6374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1197 -28.4699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4729 -26.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0885 -26.2874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6686 -29.0858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 15 1 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
10 12 1 0
12 13 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 2 0
18 14 1 0
17 19 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
18 20 1 0
25 26 1 0
22 27 1 0
27 28 1 0
27 32 2 0
28 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
29 33 1 0
28 34 2 0
32 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 524.44Molecular Weight (Monoisotopic): 523.0749AlogP: 5.91#Rotatable Bonds: 5Polar Surface Area: 97.62Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.25CX Basic pKa: 5.37CX LogP: 4.70CX LogD: 4.69Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -1.14
References 1. Chen C, Zhu H, Stauffer F, Caravatti G, Vollmer S, Machauer R, Holzer P, Möbitz H, Scheufler C, Klumpp M, Tiedt R, Beyer KS, Calkins K, Guthy D, Kiffe M, Zhang J, Gaul C.. (2016) Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach., 7 (8): [PMID:27563395 ] [10.1021/acsmedchemlett.6b00167 ] 2. Talukdar A, Mukherjee A, Bhattacharya D.. (2022) Fascinating Transformation of SAM-Competitive Protein Methyltransferase Inhibitors from Nucleoside Analogues to Non-Nucleoside Analogues., 65 (3.0): [PMID:35014841 ] [10.1021/acs.jmedchem.1c01208 ]